Typical dose

Typically 2-5 mg taken once daily, 30-60 minutes...

Oral Oral safety: very low

About this supplement

Extended-release or sustained-release melatonin is a pharmaceutical formulation of the hormone melatonin designed to release the active ingredient gradually over an extended period, typically 4-8 hours. Unlike immediate-release melatonin, which produces a rapid peak in blood concentration, this form aims to mimic the body's natural prolonged nocturnal melatonin secretion pattern. It is commonly used to support sleep maintenance, reduce nighttime awakenings, and improve overall sleep quality by providing a steady supply of melatonin throughout the sleep cycle. The extended-release mechanism is typically achieved through specialized coating technologies, matrix systems, or osmotic pump delivery systems that control the dissolution and absorption rate in the gastrointestinal tract.

How much to take

Typical amount
Typically 2-5 mg taken once daily, 30-60 minutes before bedtime. Lower doses (0.5-1 mg) are sometimes used. Clinical studies often use 2 mg prolonged-release formulations.
Suggested range
0.5-10 mg daily

Potential benefits

Benefits linked to this supplement form:

Things to watch for

Possible side effects linked to this form:

Health goals

Needs and goals this form may help with:

Other forms of Melatonin

Compare absorption and active amounts with sibling forms:

Technical details â–¼

Chemical ID (CAS)

73-31-4

Formula

C13H16N2O2

Physical properties

Typically appears as white to off-white crystalline powder. Melatonin is sparingly soluble in water but soluble in organic solvents like ethanol and DMSO. Extended-release formulations are usually compressed into tablets or capsules with specialized coatings or matrices that control dissolution. The pure compound melts at approximately 116-118°C.

How it’s made

Extended-release melatonin is produced through pharmaceutical manufacturing processes. Synthetic melatonin (typically produced via chemical synthesis from starting materials like 5-methoxyindole) is blended with release-controlling excipients such as hydrophilic polymers (e.g., hydroxypropyl methylcellulose), waxes, or insoluble matrices. The mixture is then compressed into tablets or filled into capsules. Coating technologies may involve applying semi-permeable membranes or multiple layers that dissolve at different pH levels or times to achieve sustained release. Quality control ensures consistent release profiles.